NEULIFE THERAPY LIMITED

Company Registration Number:
15205398 (England and Wales)

Unaudited micro entity accounts for the year ended 31 October 2024

Period of accounts

Start date: 11 October 2023

End date: 31 October 2024

NEULIFE THERAPY LIMITED

Contents of the Financial Statements

for the Period Ended 31 October 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

NEULIFE THERAPY LIMITED

Company Information

for the Period Ended 31 October 2024




Director: Thomas Miller
Registered office: 159
Lentons Lane
Aldermans Green
Coventry
England
CV2 1NZ
Company Registration Number: 15205398 (England and Wales)

NEULIFE THERAPY LIMITED

Directors' Report Period Ended 31 October 2024

The directors present their report with the financial statements of the company for the period ended 31 October 2024

Principal Activities

The principal activity of the company during the year continued to be The provision of physiotherapy services.

Directors

The director(s) shown below were appointed to the company during the period
Thomas Miller
11 October 2023

This report was approved by the board of directors on 17 June 2025
And Signed On Behalf Of The Board By:

Name: Thomas Miller
Status: Director

NEULIFE THERAPY LIMITED

Profit and Loss Account

for the Period Ended 31 October 2024

13 months to
31 Oct 2024
£
Turnover 6,350
Income from coronavirus (COVID-19) business support grants 0
Other Income 0
Cost of Materials ( 0 )
Staff Costs ( 4,160 )
Depreciation and Writeoffs ( 0 )
Other charges ( 2,133 )
Tax on Profit ( 11 )
Profit or (Loss) for Period 46

NEULIFE THERAPY LIMITED

Balance sheet

As at 31 October 2024

13 months to
31 Oct 2024
£
Called up share capital not paid: 0
Fixed Assets: 0
Current assets: 57
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: ( 0 )
Net current assets (liabilities): 57
Total assets less current liabilities: 57
Creditors: amounts falling due after more than one year: ( 0 )
Provision for liabilities: ( 11 )
Accruals and deferred income: ( 0 )
Total net assets (liabilities): 46
Capital and reserves: 46

NEULIFE THERAPY LIMITED

Balance sheet continued

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 17 June 2025
And Signed On Behalf Of The Board By:

Name: Thomas Miller
Status: Director

The notes form part of these financial statements

NEULIFE THERAPY LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 1. Employee Information

    Average number of employees: 1

NEULIFE THERAPY LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 2. Off balance sheet disclosure

    No